Dr Nageen Hashmi Scientific Assessor, Advertising Post-Licensing Division
Medicines and Healthcare products Regulatory Agency
Market Towers, 1 Nine Elms Lane
London SW8 5NQ	11 November 2005

 

Dear Dr Hashmi,

Your Ref: NH/efexorcomplaint/112005

Thank you for your letter of 9 November, responding to our complaint about the advertisement for Efexor XL (venlafaxine) in the BMJ of 16 April 2005. Your letter does not attempt to explain why it took seven months to resolve this complaint; this is one reason for my now requesting further information. Please treat this as a formal FOIA request for the following:

Copies of all documents and records directly relating to the vetting of this advertisement by the MHRA, prior to its publication, including all communications between Wyeth and the MHRA relating thereto.

Copies of all documents and records directly relating to the investigation and handling of complaints about this advertisement, including all communications between Wyeth and the MHRA relating thereto.

Thank you for your attention. I look forward to hearing from you within 20 working days.

Yours sincerely,
Charles Medawar

CLICK HERE TO READ ON